These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29189740)

  • 1. Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications.
    Hays EM; Duan W; Shigdar S
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29189740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer-Based In Vivo Therapeutic Targeting of Glioblastoma.
    Cesarini V; Scopa C; Silvestris DA; Scafidi A; Petrera V; Del Baldo G; Gallo A
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32957732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
    Delač M; Motaln H; Ulrich H; Lah TT
    Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamers: ushering in new hopes in targeted glioblastoma therapy.
    Chatterjee D; Bhattacharya S; Kumari L; Datta A
    J Drug Target; 2024 Nov; 32(9):1005-1028. PubMed ID: 38923419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotide aptamers for glioma targeting: an update.
    Camorani S; Cerchia L
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):126-37. PubMed ID: 25924917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer-targeted oligonucleotide theranostics: a smarter approach for brain delivery and the treatment of neurological diseases.
    Sriramoju B; Kanwar R; Veedu RN; Kanwar JR
    Curr Top Med Chem; 2015; 15(12):1115-24. PubMed ID: 25866271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamers as remarkable diagnostic and therapeutic agents in cancer treatment.
    Lassalle HP; Marchal S; Guillemin F; Reinhard A; Bezdetnaya L
    Curr Drug Metab; 2012 Oct; 13(8):1130-44. PubMed ID: 22380008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamers: new arrows to target dendritic cells.
    Ganji A; Varasteh A; Sankian M
    J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamers: Potential Diagnostic and Therapeutic Agents for Blood Diseases.
    Aljohani MM; Cialla-May D; Popp J; Chinnappan R; Al-Kattan K; Zourob M
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of DNA aptamers for malignant brain tumor gliosarcoma cell recognition and clinical tissue imaging.
    Wu Q; Wu L; Wang Y; Zhu Z; Song Y; Tan Y; Wang XF; Li J; Kang D; Yang CJ
    Biosens Bioelectron; 2016 Jun; 80():1-8. PubMed ID: 26802746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamers as innovative diagnostic and therapeutic agents in the central nervous system.
    de Franciscis V; Esposito CL; Catuogno S; Cellai L; Cerchia L
    CNS Neurol Disord Drug Targets; 2009 Nov; 8(5):393-401. PubMed ID: 19702567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in aptamer selection methods and applications.
    Yüce M; Ullah N; Budak H
    Analyst; 2015 Aug; 140(16):5379-99. PubMed ID: 26114391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment.
    Reinemann C; Strehlitz B
    Swiss Med Wkly; 2014 Jan; 144():w13908. PubMed ID: 24395443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in SELEX and application of aptamers in the central nervous system.
    Yang Y; Yang D; Schluesener HJ; Zhang Z
    Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA aptamers from whole-cell SELEX as new diagnostic agents against glioblastoma multiforme cells.
    Wu Q; Wang Y; Wang H; Wu L; Zhang H; Song Y; Zhu Z; Kang D; Yang C
    Analyst; 2018 May; 143(10):2267-2275. PubMed ID: 29708252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
    Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
    Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy.
    Gao H; Qian J; Yang Z; Pang Z; Xi Z; Cao S; Wang Y; Pan S; Zhang S; Wang W; Jiang X; Zhang Q
    Biomaterials; 2012 Sep; 33(26):6264-72. PubMed ID: 22683171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-SELEX aptamer for highly specific radionuclide molecular imaging of glioblastoma in vivo.
    Wu X; Liang H; Tan Y; Yuan C; Li S; Li X; Li G; Shi Y; Zhang X
    PLoS One; 2014; 9(6):e90752. PubMed ID: 24603483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.